Stella D. Calobrisi

Mayo Foundation for Medical Education and Research, Рочестер, Michigan, United States

Are you Stella D. Calobrisi?

Claim your profile

Publications (9)28.88 Total impact

  • Ashif Jaffer · Carl F Schanbacher · Stella D Calobrisi · W P Daniel Su
    Archives of Dermatology 02/2003; 139(1):93-8. DOI:10.1001/archderm.139.1.93-a · 4.31 Impact Factor
  • Dawn S Allison · Rokea A El-Azhary · Stella D Calobrisi · Charles H Dicken
    [Show abstract] [Hide abstract]
    ABSTRACT: Pityriasis rubra pilaris (PRP) is an uncommon dermatosis in children. Few long-term studies on the treatment and prognosis of PRP in children have been performed. Our purpose was to retrospectively review the clinical course and treatment of all cases of PRP in children 19 years or younger who were seen at the Mayo Clinic. The clinical courses of the 30 patients with PRP seen at the Mayo Clinic between 1975 and 1997 were reviewed. The most common presenting form of PRP in children is the type III juvenile form (Griffiths' criteria). Treatment ranged from topical steroids, tar, and ultraviolet B to systemic retinoids and methotrexate. The best response was obtained with isotretinoin; 5 of 6 patients showed 90% to 100% clearing within 6 months of treatment. Follow-up information was obtained by questionnaire and was available for 83% of patients. Overall, 43% had 90% to 100% resolution of their disease, 23% had a moderate response (30%-90% improvement), and 17% had a poor response (<30% improvement). One patient reported spontaneous resolution. Seventeen percent of those who had total clearing had recurrence of PRP within 1 year. PRP in children is a noninherited dermatosis with no sex predilection, occurring mainly in the type III classic juvenile form. Retinoids should be considered as first-line treatment for PRP. Recurrence rate, previously thought to be rare, was about 17% in our population.
    Journal of the American Academy of Dermatology 09/2002; 47(3):386-9. DOI:10.1067/mjd.2002.124619 · 5.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Telemedicine has the potential to revolutionize the delivery of dermatologic care to underserved areas. Our purpose was to compare diagnoses from two types of dermatology consultations: telemedicine using store-and-forward (SAF) technology, and traditional face-to-face (FTF) office visits. Skin conditions were imaged with a consumer-grade digital camera. A standardized template was used to collect historical data. Information was stored in a secured database for access by 2 or 3 board-certified dermatologists. Results from the FTF visit were used to assess the accuracy of the SAF diagnoses. A total of 106 dermatologic conditions in 92 patients were included. Concordance between FTF and SAF diagnoses was high, ranging from 81% to 89% for all 3 dermatologists. Clinically relevant disagreement occurred in only 4% to 8% of cases. Remaining disagreements did not affect patient care. Diagnostic confidence and image quality affected agreement. When cases of high confidence were analyzed separately, agreement increased to 88% to 100%. This increase was substantiated by means of a chi-square test between the high confidence and low confidence groups, which demonstrated statistical significance (P <. 005) for all dermatologists. Similarly, when cases of above average image quality were considered, agreement increased to 84% to 98%. Again this difference was substantiated by means of a chi-square test between adequate and poor images, with statistical significance for two dermatologists (P <.001). Accuracy was comparable between disease types with the exception of benign neoplasms, which demonstrated agreement of 22% to 46%. These data support the use of existing digital technology to construct an accurate SAF teledermatology system. The inexpensive camera and widely available computer equipment make this an extremely affordable system. Furthermore, participating dermatologists appear well aware of system limitations, as reflected in the increased agreement for high confidence cases. Additional investigation of the accuracy of teledermatology for benign neoplasms is warranted.
    Journal of the American Academy of Dermatology 05/2000; 42(5 Pt 1):776-83. DOI:10.1067/mjd.2000.104519 · 5.00 Impact Factor
  • Marilyn G. Liang · James A. Rooney · K.Hable Rhodes · Stella D. Calobrisi
    [Show abstract] [Hide abstract]
    ABSTRACT: Cutaneous tuberculosis remains a rare entity in the United States. We describe a case of cutaneous tuberculosis in a child.
    Journal of the American Academy of Dermatology 12/1999; 41(5 Pt 2):860-2. DOI:10.1016/S0190-9622(99)70346-4 · 5.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 14-year-old adolescent girl presented with a 2-year history of an exquisitely tender, vegetating cheilitis. Because of this, she was unable to drink fluids and was repeatedly hospitalized for dehydration and pain management. Lip and skin biopsies, as well as multiple laboratory studies did not support a definitive diagnosis. After 2 years, a diagnosis of factitial cheilitis was finally established.
    Pediatric Dermatology 01/1999; 16(1):12-5. DOI:10.1046/j.1525-1470.1999.99003.x · 1.52 Impact Factor
  • J Alonso-Llamazares · R S Rogers · J R Oursler · S D Calobrisi
    [Show abstract] [Hide abstract]
    ABSTRACT: Bullous pemphigoid is a chronic immunobullous disease of the elderly. Classically, tense, pruritic blisters develop on normal or erythematous skin. These may be preceded by a prodromal pruritic, urticarial, or eczematous eruption. Occasionally, patients may develop generalized pruritus without blisters as a prodrome of bullous pemphigoid. The records of the patients were reviewed. Biopsy specimens were studied by light and immunofluorescence microscopy. Serum specimens were studied by indirect immunofluorescence techniques including the salt-split skin technique. We studied six elderly patients presenting with generalized pruritus as the dominant or single presenting feature of early bullous pemphigoid. Two of the six had rare vesicles at presentation. All had excoriations and one each presented with minimal urticarial or eczematous papules. Routine skin biopsies were largely nonspecific. All patients had confirmation of their diagnosis by either indirect or direct immunofluorescence testing or both. All six patients had their disease completely controlled by their treatment. The clinical presentation of the six patients in our series and the eight previously reported patients should be regarded as an unusual prodromal manifestation of bullous pemphigoid characterized by generalized pruritus without primary skin lesions. This presentation could be described as "pruritic pemphigoid," because it joins the remarkable clinical finding of generalized pruritus with the underlying diagnosis of bullous pemphigoid. Elderly patients with severe or persistent unexplained generalized pruritus merit immunofluorescence testing to exclude bullous pemphigoid as the cause of the generalized pruritus. Establishing an early diagnosis permits the prompt institution of effective therapy with dapsone or systemic corticosteroids with an excellent prognosis for complete control of the disease.
    International Journal of Dermatology 08/1998; 37(7):508-14. · 1.23 Impact Factor
  • Stella D. Calobrisi · Jeffery S. Garland · Nancy B. Esterly
    [Show abstract] [Hide abstract]
    ABSTRACT: Lipoblastomatosis is a benign tumor of embryonic fat that is more common in male infants. It occurs more frequently in the soft tissues of the extremities. The diagnosis is made by biopsy, which shows globules of lipocytes and lipoblasts mixed with spindled and myxoid cells. MRI demonstrates fat infiltrating fascia and muscle. The infant described had clinical, histologic, and radiologic findings consistent with this diagnosis. Because of concern that total excision would compromise function, a debulking procedure is planned.
    Pediatric Dermatology 05/1998; 15(3):210-3. DOI:10.1046/j.1525-1470.1998.1998015210.x · 1.52 Impact Factor
  • S D Calobrisi · B A Drolet · N B Esterly
    Pediatrics 04/1998; 101(3 Pt 1):471-3. DOI:10.1542/peds.101.3.471 · 5.30 Impact Factor
  • A. Jaffer · C. F. Schanbacher · S. D. Calobrisi · W. P. Su

Publication Stats

187 Citations
28.88 Total Impact Points

Institutions

  • 2000
    • Mayo Foundation for Medical Education and Research
      Рочестер, Michigan, United States
  • 1999
    • Medical College of Wisconsin
      • Department of Dermatology
      Milwaukee, Wisconsin, United States
  • 1998–1999
    • Mayo Clinic - Rochester
      • Department of Dermatology
      Rochester, Minnesota, United States